LEVOTHYROXINE SODIUM

Product NDC
70518-4435
11-digit product format
705184435
Labeler code
70518
Product ID
70518-4435_5b34ba7d-5b26-0e72-e063-6294a90ae28d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
LEVOTHYROXINE SODIUM
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA211417
Marketing category
ANDA
Marketing start
2025-08-12
Substance
LEVOTHYROXINE SODIUM
Active strength
75 ug/1
Pharmacologic classes
Thyroxine [CS], l-Thyroxine [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A211417-001LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-002LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-003LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-004LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-005LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-006LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-007LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-008LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-009LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-010LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-011LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21
A211417-012LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 48 matching rows.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 9 · 336 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A211417-001LEVOTHYROXINE SODIUM0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-002LEVOTHYROXINE SODIUM0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-003LEVOTHYROXINE SODIUM0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-004LEVOTHYROXINE SODIUM0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-005LEVOTHYROXINE SODIUM0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-006LEVOTHYROXINE SODIUM0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-007LEVOTHYROXINE SODIUM0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-008LEVOTHYROXINE SODIUM0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-009LEVOTHYROXINE SODIUM0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-010LEVOTHYROXINE SODIUM0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-011LEVOTHYROXINE SODIUM0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-012LEVOTHYROXINE SODIUM0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21d4dbc9d85df4…
2026-10-15 13:18:302026-09A211417-001LEVOTHYROXINE SODIUM0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-002LEVOTHYROXINE SODIUM0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-003LEVOTHYROXINE SODIUM0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-004LEVOTHYROXINE SODIUM0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-005LEVOTHYROXINE SODIUM0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-006LEVOTHYROXINE SODIUM0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-007LEVOTHYROXINE SODIUM0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-008LEVOTHYROXINE SODIUM0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-009LEVOTHYROXINE SODIUM0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-010LEVOTHYROXINE SODIUM0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-011LEVOTHYROXINE SODIUM0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-10-15 13:18:302026-09A211417-012LEVOTHYROXINE SODIUM0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21c2088c7a36db…
2026-09-14 22:38:342026-08A211417-001LEVOTHYROXINE SODIUM0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-002LEVOTHYROXINE SODIUM0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-003LEVOTHYROXINE SODIUM0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-004LEVOTHYROXINE SODIUM0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-005LEVOTHYROXINE SODIUM0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-006LEVOTHYROXINE SODIUM0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-007LEVOTHYROXINE SODIUM0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-008LEVOTHYROXINE SODIUM0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-009LEVOTHYROXINE SODIUM0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-010LEVOTHYROXINE SODIUM0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-011LEVOTHYROXINE SODIUM0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-09-14 22:38:342026-08A211417-012LEVOTHYROXINE SODIUM0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-2184e616aacf4f…
2026-08-18 06:07:402026-07A211417-001LEVOTHYROXINE SODIUM0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21caaa826d4ba7…
2026-08-18 06:07:402026-07A211417-002LEVOTHYROXINE SODIUM0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21caaa826d4ba7…
2026-08-18 06:07:402026-07A211417-003LEVOTHYROXINE SODIUM0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21caaa826d4ba7…
2026-08-18 06:07:402026-07A211417-004LEVOTHYROXINE SODIUM0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3,AB42022-12-21caaa826d4ba7…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 19 · 732 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A211417-001AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-001AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-001AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-001AB44d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-002AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-002AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-002AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-002AB44d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-003AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-003AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-003AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-003AB44d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-004AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-004AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-004AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-004AB44d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-005AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-005AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-005AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-005AB44d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-006AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-006AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-006AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-006AB44d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-007AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-007AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-007AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-007AB44d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-008AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-008AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-008AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-008AB44d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-009AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-009AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-009AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-009AB44d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-010AB11d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-010AB22d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-010AB33d4dbc9d85df4…
2026-11-14 07:37:172026-10A211417-010AB44d4dbc9d85df4…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
LEVOTHYROXINE SODIUM
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LEVOTHYROXINE SODIUM75 ug/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9J765S329GInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
966222Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9ad82faf-3734-42a1-befe-f6197b27f534Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
97c252d3-9bb8-4530-bb44-9824dc7cf556Product name620250729
6c43b71c-35e6-4db3-ba24-c6ef42ff7003Product name320240207
890fd4bf-1a80-42b7-be1b-2d0259d5f0c8Product name520240207
c8ad26bf-af73-460b-b74e-1eff16cc4f9fProduct name520240207
01383843-4069-43cf-aa76-dc17a6f9f8c4Product name220230123
978cca7d-a938-4791-8322-da48d90a63efProduct name120230113
65f86ba3-8816-4e12-899b-18290c8de551Product name220210614
f16ab90f-08c2-40be-a543-66d9827cd1f3Product name120210601
6a33ec05-2ae2-45e5-ab82-2d94b3303923Product name120190709
93355a10-1c44-4c92-a11d-7d995e0200d9Product name120190219

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70518-4435-0LEVOTHYROXINE SODIUM90 in 1 BOTTLETABLET901

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 38 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMNuCare Pharmaceuticals,Inc.5da80d6d-4895-ad6c-e063-6394a90ae6f52026-10-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMNuCare Pharmaceuticals,Inc.5da82b4e-bf84-c482-e063-6394a90addf92026-10-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMBryant Ranch Prepack48a366d8-f5ac-47b0-84e3-f88251def70c2026-09-28Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions01d2c8c9-db54-4002-8f79-4ec3965310242026-09-18Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions255ad500-6656-4cd0-b4d1-10cc22f9e61b2026-09-18Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutionscee5ca2e-4780-4c54-a895-0f9fb2986c1e2026-09-18Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutionsb45189d2-529b-4d5a-89a9-697bcd61fdb42026-09-17Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions5ae839f4-bca9-4601-ba80-f2018b9142e42026-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutionse9a9b3c8-2ebf-422f-a60b-8d2bd806f3f62026-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions1cacd07a-6fcc-4cdb-aee8-7a62493eb5792026-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions0266d5d9-edb3-4d0d-ab24-5d1d65f7e5012026-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions2622a029-5f4f-4675-9e3d-66e7aa12ce9d2026-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMREMEDYREPACK INC.6f4bc4be-17a7-4273-a8d9-a1ff036dea0e2026-09-11Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMREMEDYREPACK INC.9ad82faf-3734-42a1-befe-f6197b27f5342026-09-11Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
ndc (product): 70518-4435
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMREMEDYREPACK INC.817656c7-3b6d-4f94-83e6-dec9e0d35c842026-09-11Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMNorthStar RxLLC58f4dc90-3648-49dc-a7e1-baf918a773b52026-08-20Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMCoupler LLC5383a4d8-319a-5bf6-e063-6294a90a54972026-06-05Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMNuCare Pharmaceuticals,Inc.510349d0-6397-7e2b-e063-6394a90a8a682026-05-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutions853d9e86-2b5b-4967-8c22-70ad34f034182026-02-20Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMA-S Medication Solutionsb42fe9dd-8383-4839-9eab-393de388da712026-02-20Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211417
application number: ANDA211417

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
966222levothyroxine sodium 75 MCG Oral TabletPSN9ad82faf-3734-42a1-befe-f6197b27f5341
966222levothyroxine sodium 0.075 MG Oral TabletSCD9ad82faf-3734-42a1-befe-f6197b27f5341
966222levothyroxine sodium 75 MCG Oral TabletSY9ad82faf-3734-42a1-befe-f6197b27f5341

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
70518-4435-07051844350090 TABLET in 1 BOTTLE (70518-4435-0) 90 tablet2025-08-12NoNoCurrent